Amazon’s online pharmacy is clashing with a company that collects health information, and it could have huge implications for the future of healthcare

This story requires our BI Prime membership. To read the full article,

Now with the backing of Amazon, PillPack especially has the healthcare industry at attention. At the time Amazon announced it was buying PillPack, the deal ReMy told Business Insider that it works with many data providers, including Surescripts, and a number of clients, including PillPack. In particular, the company said it works with organizations"through the final few miles of care delivery," which include pharmacies and doctors.PillPack had been informed in July that ReMy had been told by Surescripts that it would soon no longer be able to share that information with PillPack.

"Given that Surescripts is, to our knowledge, the sole clearinghouse for medication history in the United States, the core question is whether Surescripts will allow customers to share their medication history with pharmacies and if not, why not?" Miller said in the statement.Surescripts on Monday cut off ReMy's access to its data, saying ReMy was sharing the medication history information with a pharmacy.

Traditionally, pharmacies are sent a prescription to fill from a doctor. The pharmacist and her team then dispense the medication to the patient. They can check with the patient's pharmacy benefit manager to understand both what the patient will have to pay and whether the pills she's taking will have any bad interactions with other drugs that patient's on.Amazon is threatening the future of independent pharmacies. Here's how they're fighting back.

Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen

Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.

Here's why it's so difficult for apparel companies to navigate the trade warsLiz Dunn, founder and CEO of Pro4ma, joins 'Squawk Box' to discuss how retail might be affected by the latest developments in the U.S.-China trade war. SquawkCNBC when it comes to retail who is really at fault. And then you come to retail who comes to a person who makes certain things that don't last long they're called junk items. Instead of fine art instead of statues instead of food instead of Home building. And nature reserves. Nothing SquawkCNBC but those beef exports!
Herkunft: CNBC - 🏆 12. / 72 Weiterlesen »